Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shengxuening Tablet for Chemotherapy-related Anemia in Hematologic Tumors
NCT05784870Phase 3Unknown
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of shengxuening in cancer-related anemia (CRA), sponsored by Zhongnan Hospital of Wuhan University. Status: unknown.
02
Drugs
shengxuening
03
Conditions
cancer-related anemia (CRA)
Beyond the preview
Go deeper on NCT05784870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05784870.